USANA Health Sciences (USNA) Misses Q2 EPS by 50c; updates guidance
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $15.55 +3.94%
EPS Growth %: +386.7%
Financial Fact:
Total operating expenses: 173.41M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +386.7%
Financial Fact:
Total operating expenses: 173.41M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q2 EPS of ($0.07), $0.50 worse than the analyst estimate of $0.43. Revenue for the quarter came in at $223 million versus the consensus estimate of $235 million.
GUIDANCE:
USANA Health Sciences sees FY2026 EPS of $0.76, versus the consensus of $2.12. USANA Health Sciences sees FY2026 revenue of $750 million, versus the consensus of $945.1 million.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Explosions heard on Iran's Kharg island - MEHR
- Meta launches Muse, a personal AI agent with secure virtual machine
- Tenable to integrate Anthropic's Claude into its security platform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
